Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-08-28

Clinical Trial Update: Hypo-Fractionated Radiation Therapy for Localized Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating hypo-fractionated radiation therapy for localized prostate cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Prostate Cancer | Phase 1 | Status: TERMINATED